Submitted by Jean Medeiros (jeanletras@uepb.edu.br) on 2016-03-02T17:03:56Z No. of bitstreams: 2 license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) PDF - Airlla Laana de Medeiros Cavalcanti.pdf: 2086060 bytes, checksum: b74e6eb69ebe6e0583efc0e2d23bedac (MD5) / Approved for entry into archive by Secta BC (secta.csu.bc@uepb.edu.br) on 2016-06-13T20:33:03Z (GMT) No. of bitstreams: 2 PDF - Airlla Laana de Medeiros Cavalcanti.pdf: 2086060 bytes, checksum: b74e6eb69ebe6e0583efc0e2d23bedac (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Made available in DSpace on 2016-06-13T20:33:10Z (GMT). No. of bitstreams: 2 PDF - Airlla Laana de Medeiros Cavalcanti.pdf: 2086060 bytes, checksum: b74e6eb69ebe6e0583efc0e2d23bedac (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) Previous issue date: 2015-02-13 / Some inflammatory skin diseases are treated with drugs carried on conventional dosage forms that often fail to achieve adequate concentrations in the tissue to generate maximum pharmacological effect. Pentoxifylline (PTX) is one of these drugs widely studied due to its anti-inflammatory activity by inhibiting the production of TNFα and other proinflammatory cytokines. The use of PTX incorporated into microemulsions (ME) would be a novel alternative for the treatment of inflammatory skin disorders. This new drug delivery system can be used topically and can be able to increase the permeation through skin and the effectiveness of several drugs compared to conventional treatments. The aim of this work was to develop a microemulsion containing PTX (PTX-ME) for topical use. The formulation obtained from the pseudoternary phase diagrams was characterized and evaluated using methods such as polarized light microscopy (MLP), differential scanning calorimetry (DSC) and transmission electron microscopy (TEM). The in vitro release profile was determined using the model of Franz cells and antiedematogenic activity in vivo was determined using the technique of paw edema induced by carrageenan. The ME was composed of distilled water (5%), acid–capric/caprylic triglycerides (51%), Tween 80 (39.6%) and Brij TM 52 (4.4%). Analyzes of MLP, DSC, and TEM were able to confirm that the ME obtained was water-in-oil (W/O) type. The formulation was thermodynamically stable against thermic stress. Beside this, it had physicalchemical characteristics that allow its topical use. In vitro release of PTX-ME followed the Higuchi kinetic model. Additionally, it showed significant anti-inflammatory activity in paw edema induced by carrageenan in all stages of the assay. Consequently, the PTX-ME showed an interesting alternative for treatment of dermatological disorders. / Algumas doenças dermatológicas inflamatórias são tratadas com fármacos veiculados em formas farmacêuticas convencionais, que muitas vezes não atingem concentrações teciduais adequadas para gerar o efeito farmacológico máximo. A pentoxifilina (PTX) é um desses fármacos e tem sido amplamente estudada com relação a sua atividade anti-inflamatória por inibir a produção de TNF-α e outras citocinas pró-inflamatórias. O uso da PTX incorporada a uma microemulsão (ME) seria uma alternativa inédita para o tratamento de afecções dermatológicas inflamatórias. Esse novo sistema transportador de fármaco pode ser utilizado topicamente e é capaz de aumentar a permeação cutânea e a eficácia de vários fármacos em relação aos tratamentos convencionais. O objetivo deste trabalho foi desenvolver um sistema microemulsionado contendo PTX para aplicação tópica. A formulação obtida a partir de um diagrama de fase pseudoternário foi caracterizada e avaliada utilizando métodos como microscopia de luz polarizada (MLP), calorimetria exploratória diferencial (DSC) e microscopia eletrônica de transmissão (MET). O perfil de liberação in vitro foi determinado utilizando o modelo de células de Franz e a atividade antiedematogênica in vivo foi determinada através da técnica de edema de pata induzido por carragenina. A ME desenvolvida foi constituída por 5% de água destilada, 51% de triglicerídeos do ácido cáprico e caprílico, 39,6% de Tween ® 80 e 4,4% Brij ® 52. Através das análises de MLP, DSC e MET foi possível confirmar a estruturação do sistema como ME do tipo água em óleo (A/O). A formulação apresentou-se estável frente a estresses térmicos, além de possuir características físico-químicas que possibilitam seu uso por via tópica. A liberação in vitro da ME-PTX obedeceu ao modelo cinético de Higuchi e apresentou atividade anti-inflamatória significativa em edema de pata induzido por carragenina em todas as etapas do ensaio. Portanto, pôde-se concluir, que a veiculação da PTX através de um sistema microemulsionado mostrou-se uma alternativa interessante e inédita para o tratamento de afecções dermatológicas.

Catalytic combustion is a promising technology for heat and power applications, especially gas turbines. By using catalytic combustion ultra low emissions of nitrogen oxides (NOX), carbon monoxide (CO) and unburned hydrocarbons (UHC) can be reached simultaneously, which is very difficult with conventional combustion technologies. Besides achieving low emission levels, catalytic combustion can stabilize the combustion and thereby be used to obtain stable combustion with low heating-value gases. This thesis is focused on the high-temperature part of the catalytic combustor. The level of performance demanded on this part has proven hard to achieve. In order to make the catalytic combustor an alternative to the conventional flame combustor, more stable catalysts with higher activity have to be developed. The objective of this work was to develop catalysts with higher activity and stability, suitable for the high-temperature part of a catalytic combustor fueled by natural gas. Two template-based preparation methods were developed for this purpose. One method was based on soft templates (microemulsion) and the other on hard templates (carbon). Supports known for their stability, magnesia and hexaaluminate, were prepared using the developed methods. Catalytically active materials, perovskite (LaMnO3) and ceria (CeO2), were added to the supports in order to obtain catalysts with high activities and stabilities. The supports were impregnated with active materials by using a conventional technique as well as by using the microemulsion technique. It was shown that the microemulsion method can be used to prepare catalysts with higher activity compared to the conventional methods. Furthermore, by using a microemulsion to apply active materials onto the support a significantly higher activity was obtained than when using the conventional impregnation technique. Since the catalysts will operate in the catalytic combustor for extended periods of time under harsh conditions, an aging study was performed on selected catalysts prepared by the microemulsion technique. The stability of the catalysts was assessed by measuring the activity before and after aging at 1000 C in humid air for 100 h. One of the most stable catalysts reported in the literature, LMHA (manganese-substituted lanthanum hexaaluminate), was included in the study for comparative purposes. The results showed that LMHA deactivated much more strongly compared to several of the catalysts consisting of ceria supported on lanthanum hexaaluminate prepared by the developed microemulsion method. Carbon templating was shown be a very good technique for the preparation of high-surface-area hexaaluminates with excellent sintering resistance. It was found that the pore size distribution of the carbon used as template was a crucial parameter in the preparation of hexaaluminates. When a carbon with small pores was used as template, the formation of the hexaaluminate crystals was strongly inhibited. This resulted in a material with poor sintering resistance. On the other hand, if a carbon with larger pores was used as template, it was possible to prepare materials with hexaaluminate as the major phase. These materials were, after accelerated aging at 1400 C in humid air, shown to retain surface areas twice as high as reported for conventionally prepared materials. / QC 20100719

Synthesis of copper nanoparticles by a colloidal recipe in a two-phase liquid-liquid mixture (toluene/water) was investigated. The synthesis recipe used in this work was originally applied for the fabrication of alkylamine-capped gold nanoparticles. This method involves transferring metal cations from the aqueous layer to the organic one by the phase transfer reagent, tetraoctylammonium bromide, followed by reduction with sodium borohydride in the presence of oleylamine, which was used as the stabilising ligand. Several modifications were made to the original recipe to produce copper nanoparticles with high degrees of purity and stability. These particles are potentially applicable in various industries and are considered as an alternative for expensive metal nanoparticles, such as gold, silver, and platinum. Due to the high tendency of copper for oxidation, all of the synthesis experiments were carried out in a glove box under the flow of an inert gas (N2 or Ar). The concentration of Cl− was initially increased to form anionic complexes of copper that could later react with the cationic phase transfer reagent. This modification was followed to enhance the efficiency of the transferring step; however, the presence of anion, Cl−, at the surface of the synthesized particles was reported to change their properties; thus, increasing chloride concentration was eventually ignored. The decanting of two phases prior to the reduction step was also investigated to examine whether the site of the reduction reaction could be limited to cores of reverse micelles. The aggregated nanoparticles, which were fabricated by reducing the decanted organic phase, were heated after the synthesis at 150°C for 30 minutes to obtain a light green solution of nanoparticles. However, further characterization was not possible due to the hydrocarbon impurities. Dodecane, which was employed as the solvent for post-synthesis heating procedure, is believed to result in these impurities. Further investigation is required to explain the mechanism by which post-synthesis heating facilitates nanoparticle stabilization. Duplication of the original recipe for copper in an inert atmosphere resulted in a mixture of assembled layers of separated copper nanocrystals with an average size of ~ 5 nm and aggregated clusters of cubic copper (I) oxide nanoparticles. The possible mechanism for this division is believed to be the presence of the phase transfer reagent capped to the surface of a portion of synthesized particles leading to their metastability.

Synthesis of copper nanoparticles by a colloidal recipe in a two-phase liquid-liquid mixture (toluene/water) was investigated. The synthesis recipe used in this work was originally applied for the fabrication of alkylamine-capped gold nanoparticles. This method involves transferring metal cations from the aqueous layer to the organic one by the phase transfer reagent, tetraoctylammonium bromide, followed by reduction with sodium borohydride in the presence of oleylamine, which was used as the stabilising ligand. Several modifications were made to the original recipe to produce copper nanoparticles with high degrees of purity and stability. These particles are potentially applicable in various industries and are considered as an alternative for expensive metal nanoparticles, such as gold, silver, and platinum. Due to the high tendency of copper for oxidation, all of the synthesis experiments were carried out in a glove box under the flow of an inert gas (N2 or Ar). The concentration of Cl− was initially increased to form anionic complexes of copper that could later react with the cationic phase transfer reagent. This modification was followed to enhance the efficiency of the transferring step; however, the presence of anion, Cl−, at the surface of the synthesized particles was reported to change their properties; thus, increasing chloride concentration was eventually ignored. The decanting of two phases prior to the reduction step was also investigated to examine whether the site of the reduction reaction could be limited to cores of reverse micelles. The aggregated nanoparticles, which were fabricated by reducing the decanted organic phase, were heated after the synthesis at 150°C for 30 minutes to obtain a light green solution of nanoparticles. However, further characterization was not possible due to the hydrocarbon impurities. Dodecane, which was employed as the solvent for post-synthesis heating procedure, is believed to result in these impurities. Further investigation is required to explain the mechanism by which post-synthesis heating facilitates nanoparticle stabilization. Duplication of the original recipe for copper in an inert atmosphere resulted in a mixture of assembled layers of separated copper nanocrystals with an average size of ~ 5 nm and aggregated clusters of cubic copper (I) oxide nanoparticles. The possible mechanism for this division is believed to be the presence of the phase transfer reagent capped to the surface of a portion of synthesized particles leading to their metastability.

In this study, we evaluated the potential of water-in-oil microemulsions for the separation of beta-galactosidase (lactase) from other proteins. The ability of beta-galactosidase to break down the milk carbohydrate lactose gives the enzyme considerable commercial importance. The extent of solubilization of a commercial Kluyveromyces lactis preparation of beta-galactosidase into microemulsion droplets formed from 200 mM bis (2-ethylhexyl) sodium sulfosuccinate (AOT) in isooctane was measured as a function of buffer type, pH, ionic strength, and protein concentration. Our results showed that, due to the large molecular weight of beta-galactosidase (MW~ 220-240 kDa, dimeric form), the enzyme was taken up by the microemulsion droplets mainly under very low salt conditions. Based on these results, we designed a one-step separation procedure, in which a small volume of aqueous buffer containing the protein mixture is added to an organic surfactant solution. Microemulsion droplets form in the oil and capture protein impurities of smaller molecular weights, while excluding the high molecular weight target protein. This causes the beta-galactosidase to be expelled into a newly formed aqueous phase. The feasibility of this one-step process as a bioseparation tool was demonstrated on a feed consisting of an equal mixture of beta-galactosidase and the test protein beta-lactoglobulin. Recovery and separation of the two proteins was analyzed as function of buffer type, pH, ionic strength, and protein concentration. Results showed that separation was most complete at 100 mM KCl salt concentration, where the droplets were big enough to carry beta-lactoglobulin but too small for lactase. At 100 mM salt concentration, we recovered 92% of the total lactase activity in a virtually pure form. The same separation scheme was then tested on crude extract obtained from a cell culture broth of the yeast Kluyveromyces lactis. Cells of the yeast K. lactis were disrupted by minibeadbeater, forming a crude extract that was used as the feed in our separation process. A 5.4-fold purification factor of the extract was achieved, with 96% activity recovery. The results showed our one-step separation process to be an interesting method for the production of beta-galactosidase as a technical enzyme: it has the potential to achieve a continuous, large-scale partial purification of the enzyme, potentially reducing the number of steps required in downstream process.

Magnetic nanoparticles find broad applications in biomedical field such as drug delivery, hyperthermia and magnetic resonance imaging (MRI). For these applications magnetic nanoparticles need to be coated with suitable materials which are soluble, biocompatible and nontoxic. Among these materials, silica is the most often used coating material. This thesis is focused on preparation of silica coated iron oxide magnetic nanoparticles. Magnetic iron oxide nanoparticles are synthesized by thermal decomposition method. In the presence of iron acetylacetonate Fe(acac)3, a high boiling point organic solvent and a reducing agent, particle sizes ranging from about 5 nm to 7 nm were obtained. Nanoparticles were characterized by transmission electron microscopy (TEM). The obtained nanoparticles were coated with ultra thin silica shell via reverse microemulsion method. The influence of the amount of Igepal CO-520, NH4OH and TEOS was studied systematically and their amounts were optimized to yield monodisperse and well defined particles. The size of the silica coated magnetic nanoparticles and their agglomerates were determined by TEM images and particle size analyzer (zeta sizer). X-Ray photoelectron spectroscopy (XPS) was used to confirm the presence of silica whenever the coating could not be seen by TEM measurements. Magnetic nanoparticles having 4-6 nm thickness of silica shell were obtained. The results showed that the amount of surfactant Igepal CO-520 played an important role in the reaction system.

The skin, by weight, is the largest organ of the body. Human skin serves to provide several important functions that may be classified. in a general context, as protective, maintaining homeostasis and sensing. The outermost layer of the skin, the stratum corneum, has an essential role as a barrier against the transport of water and of chemical and biological agents. In this study acyclovir (ACV), an antiviral used for treating the varicella zoster virus, was used. It is sensible to say that a hydrophilic drug like acyclovir needs a delivery vehicle or penetration enhancer to permeate the skin with more ease. In an attempt to enhance the permeation of acyclovir, it was formulated in a delivery vehicle with the same formulation as for a micro-emulsion. Increasing percentages of the surfactant, Brij 97, were incorporated in the formulation to determine which of the four formulations is indeed a micro-emulsion. A gelating agent. carrageenan, was used to make the emulsion transdermally more applicable; the influence of this component on the transdermal delivery of acyclovir was also determined. Therefore the aim of this study was to determine: -The effect of a drug delivery vehicle on the transdermal delivery of acyclovir; -The specific formulation of a micro-emulsion and -The influence of a gelating agent on the transdermal delivery of acyclovir. Diffusion studies were performed in vertically mounted glass Franz diffusion cells. The epidermis of female abdominal skin, obtained after abdomeoplasty, was heat separated from the dermis. One millilitre of emulsion (0.1%: 1mg/ml ACV) was added to the skin sample in the donor side of the diffusion cell. The control solution had an equivalent amount of active in water and was added to the donor compartment in a separate experiment. The receptor phase was PBS (phosphate buffered solution). The entire receptor phase of the cells was removed every second hour and was replaced with fresh receptor phase at 37°C. The amount of acyclovir in the receptor phase was determined by HPLC analysis. The cumulative amounts of the active that permeated the skin over the 24 hour period were plotted with the slope of the graphs representing the flux in ng/cm²/h. The average flux values of the experimental cells and control cells were compared. Results of the diffusion studies without carrageenan showed that increasing the concentration of the surfactant increased the diffusion of acyclovir. Permeation studies with carrageenan had a totally different outcome. The enhancement ratio of the experimental cells was much lower than that of the control cells. However the experimental cells showed a small increase as the concentration of the surfactant increased. From VanKel dissolution studies it could be seen that release of acyclovir from the emulsion was not a problem and that the active was available for absorption. Confocal studies were done to determine whether there were any vesicles in the emulsions. Vesicles were expected in the 25% Brij 97 emulsion because it was the same formulation as a micro-emulsion, but vesicles could only be found in the 4% and 8% Brij 97 emulsion. A previous study with acyclovir and three different delivery vehicles gave enhancement ratios between 0.32 to 2.92. Values obtained in this study of the 4% and 8% Brij 97 emulsion without carrageenan were more or less the same but the 15% and 25% Brij 97 emulsion had a much higher enhancement ratio. For the emulsions with carrageenan not one exceeded an enhancement ratio of 0.57. More studies still have to be done on micro-emulsions to determine which specific concentration of surfactant forms a micro-emulsion. The active itself and its physicochemical properties also play an important role in the diffusion studies with the specific delivery vehicle and further research has to be done with different model drugs. / Thesis (M.Sc. (Pharmaceutics))--North-West University, Potchefstroom Campus, 2006.

The skin, by weight, is the largest organ of the body. Human skin serves to provide several important functions that may be classified. in a general context, as protective, maintaining homeostasis and sensing. The outermost layer of the skin, the stratum corneum, has an essential role as a barrier against the transport of water and of chemical and biological agents. In this study acyclovir (ACV), an antiviral used for treating the varicella zoster virus, was used. It is sensible to say that a hydrophilic drug like acyclovir needs a delivery vehicle or penetration enhancer to permeate the skin with more ease. In an attempt to enhance the permeation of acyclovir, it was formulated in a delivery vehicle with the same formulation as for a micro-emulsion. Increasing percentages of the surfactant, Brij 97, were incorporated in the formulation to determine which of the four formulations is indeed a micro-emulsion. A gelating agent. carrageenan, was used to make the emulsion transdermally more applicable; the influence of this component on the transdermal delivery of acyclovir was also determined. Therefore the aim of this study was to determine: -The effect of a drug delivery vehicle on the transdermal delivery of acyclovir; -The specific formulation of a micro-emulsion and -The influence of a gelating agent on the transdermal delivery of acyclovir. Diffusion studies were performed in vertically mounted glass Franz diffusion cells. The epidermis of female abdominal skin, obtained after abdomeoplasty, was heat separated from the dermis. One millilitre of emulsion (0.1%: 1mg/ml ACV) was added to the skin sample in the donor side of the diffusion cell. The control solution had an equivalent amount of active in water and was added to the donor compartment in a separate experiment. The receptor phase was PBS (phosphate buffered solution). The entire receptor phase of the cells was removed every second hour and was replaced with fresh receptor phase at 37°C. The amount of acyclovir in the receptor phase was determined by HPLC analysis. The cumulative amounts of the active that permeated the skin over the 24 hour period were plotted with the slope of the graphs representing the flux in ng/cm²/h. The average flux values of the experimental cells and control cells were compared. Results of the diffusion studies without carrageenan showed that increasing the concentration of the surfactant increased the diffusion of acyclovir. Permeation studies with carrageenan had a totally different outcome. The enhancement ratio of the experimental cells was much lower than that of the control cells. However the experimental cells showed a small increase as the concentration of the surfactant increased. From VanKel dissolution studies it could be seen that release of acyclovir from the emulsion was not a problem and that the active was available for absorption. Confocal studies were done to determine whether there were any vesicles in the emulsions. Vesicles were expected in the 25% Brij 97 emulsion because it was the same formulation as a micro-emulsion, but vesicles could only be found in the 4% and 8% Brij 97 emulsion. A previous study with acyclovir and three different delivery vehicles gave enhancement ratios between 0.32 to 2.92. Values obtained in this study of the 4% and 8% Brij 97 emulsion without carrageenan were more or less the same but the 15% and 25% Brij 97 emulsion had a much higher enhancement ratio. For the emulsions with carrageenan not one exceeded an enhancement ratio of 0.57. More studies still have to be done on micro-emulsions to determine which specific concentration of surfactant forms a micro-emulsion. The active itself and its physicochemical properties also play an important role in the diffusion studies with the specific delivery vehicle and further research has to be done with different model drugs. / Thesis (M.Sc. (Pharmaceutics))--North-West University, Potchefstroom Campus, 2006.

Triple fortification of salt with vitamin A, iron, and iodine has been investigated in the past to reduce micronutrient deficiencies in the developing world. The objective is to develop integrated nutrient delivery technology by microencapsulating a self-emulsifying drug delivery system (SEDDS) made of surfactants and a bioactive compound, retinyl palmitate. The SEDDS is used to enhance absorption of the vitamin A through food systems and to achieve targeted release of the active ingredient. Encapsulating vitamin A was difficult when using the spray dryer and the enteric coating, Aquacoat®. Losses of the micronutrient after a three month storage period ranged from 50-99% at both 25°C/20% RH and 45°C/60% RH. The result of a matrix encapsulation and poor coating formation contributed to the high losses. Further investigation of coating systems with the aim of stabilizing all three samples for a six month storage period such as using other encapsulating methods is recommended.

Triple fortification of salt with vitamin A, iron, and iodine has been investigated in the past to reduce micronutrient deficiencies in the developing world. The objective is to develop integrated nutrient delivery technology by microencapsulating a self-emulsifying drug delivery system (SEDDS) made of surfactants and a bioactive compound, retinyl palmitate. The SEDDS is used to enhance absorption of the vitamin A through food systems and to achieve targeted release of the active ingredient. Encapsulating vitamin A was difficult when using the spray dryer and the enteric coating, Aquacoat®. Losses of the micronutrient after a three month storage period ranged from 50-99% at both 25°C/20% RH and 45°C/60% RH. The result of a matrix encapsulation and poor coating formation contributed to the high losses. Further investigation of coating systems with the aim of stabilizing all three samples for a six month storage period such as using other encapsulating methods is recommended.